GlaxoSmithKline (GSK) Tops Q4 EPS by 4p
Tweet
Share
E-mail
Get Alerts GSK Hot Sheet
Join SI Premium – FREE
GlaxoSmithKline (NYSE: GSK) reported Q4 EPS of GBP0.31, GBP0.04 better than the analyst estimate of GBP0.27. Revenue for the quarter came in at GBP8.2 billion versus the consensus estimate of GBP7.98 billion.
For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Grandstand Limited (GRSD) Tops Q2 EPS by 5c; Offers Guidance
- Intellicheck (IDN) Reports In-Line Q2 EPS
- MDxHealth SA (MDXH) Misses Q2 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
